PHILADELPHIA, August 3, 2020 – PharmaVOICE today revealed that Sunny Beth White, Founder & CEO of XAVIER CREATIVE HOUSE, (XCH) has been named among the top 100 Pharma Voices. This respected annual recognition acknowledges the most inspirational, motivational, and transformational individuals throughout the life-sciences industry, whose leadership is more important than ever, given the vast disruption facing the industry and patients.
It is a great honor to be included among life-science’s top influencers. XCH caters to this industry, and we are committed to promoting the work of organizations in pharma, biotech, medical device, and health systems.
The PharmaVOICE 100 is the only awards program to recognize individuals spanning all sectors of the life-sciences industry — from academia to nonprofit organizations to big pharma to emerging biotech companies to all types of innovative companies that provide molecule-to-market services in support of moving the needle to benefit patients around the world. The result is a dynamic mix of people across a range of disciplines who are making meaningful contributions in their fields of influence. This diverse group of individuals is also unique in that they represent a wide variety of functional areas — ranging from the clinic to the C-suite.
When we introduced the PharmaVOICE 100 most inspiring people in the life-sciences industry more than 15 years ago, it began a movement,” says Taren Grom, editor, and co-founder, PharmaVOICE. “Our goal is to capture that intangible measure of a person’s influence: inspiration. Each year, our community puts thoughtful consideration into distinguishing the individuals who are driving change and redefining the landscape of the life-sciences ecosystem.”
The 2020 honorees will be introduced in the July/August PharmaVOICE 100 issue.
More about PharmaVOICE:
PharmaVOICE delivers the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry including, manufacturing, biotechnology, drug discovery, research & development, contract research, drug delivery, and device/diagnostic companies. The publication also informs decision-makers at healthcare advertising, marketing, medical education, public relations, information technology, contract sales, traditional and nontraditional media, and other service support companies and organizations.
Categories: XCH News,